An innovative device that makes the management of type 1 diabetes easier is to be reimbursed for children and teenagers. However, adults with the condition will not be reimbursed - a decision that has been criticised by the national charity, Diabetes Ireland.

The FreeStyle Libre Flash Glucose Monitoring System allows people to check their blood glucose levels as often as they want without having to prick their fingers.

The device consists of a small round sensor - about the size of a two euro coin - which is worn on the back of the upper arm for up to 14 days. A handheld reader is scanned over the sensor to upload glucose results. This takes less than one second and there is no need to draw blood.

The device has been described as a ‘game changer' by many, however, the cost can be prohibitive. The starter kit costs €169.90, which includes two 14-day sensors to cover the first month. After that, each 14-day sensor costs €59.90, so almost €120 per month.

Until now, anyone wishing to use the FreeStyle Libre had to pay privately for it, however the Department of Health has now announced that the HSE will reimburse the device for children and young adults, although with conditions.

"This innovative device will allow blood glucose levels to be monitored without invasive finger prick testing, which will be very welcome news for both parents and children. I know that some patients have to test their glucose levels up to 10 times a day and I hope that inconvenience and discomfort can be minimised for as many children and young adults as possible," commented the Minister for Health, Simon Harris.

However, while the move was welcomed by Diabetes Ireland, it queried why the device will not be reimbursed for adults too.

"Diabetes Ireland is disappointed in that this ground breaking technology which allows blood glucose levels to be monitored without invasive finger prick testing, is not being made available for every person with type 1 diabetes, based on clinical need,' it said.

It also noted that reimbursement will be confined to children and young adults who require multiple dose injections of insulin in the first instance, with a review after 12 months.

"Why is the device being restricted to persons using multiple dose injections only, as many children and young adults are now using continuous insulin infusions (insulin pumps), but equally test as frequently or more than a person on a multiple dose injection regime, yet they are also exempt from accessing the FreeStyle Libre.

The charity said it will be seeking clarification on these matters with the department.